MAZE · NASDAQ
Maze Therapeutics (MAZE) Stock Price & Fundamentals
Maze Therapeutics (MAZE) closed at $593.74 on Oct 9, 2026, down 0.54% from the previous close of $596.95.
Share price, past year
1Y +0.84%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $593.74 |
| Sep 30, 2026 | $601.18 |
| Aug 31, 2026 | $604.63 |
| Jul 31, 2026 | $628.15 |
| Jun 30, 2026 | $602.07 |
| May 29, 2026 | $590.03 |
| Apr 30, 2026 | $570.56 |
| Mar 31, 2026 | $556.93 |
| Feb 27, 2026 | $565.62 |
| Jan 30, 2026 | $583.45 |
| Dec 31, 2025 | $575.81 |
| Nov 28, 2025 | $571.53 |
| Oct 31, 2025 | $604.59 |
Key statistics
- Market cap
- $32.96B
- P/E (TTM)
- —
- EPS (TTM)
- −$2.34
- Revenue (TTM)
- —
- Net income (TTM)
- −$133.59M
- Shares outstanding
- 55.5M
- Dividend yield
- —
- 52-week range
- $533.41 – $631.30
Maze Therapeutics's market cap is $32.96B, based on a share price of $593.74 and 55.5M shares outstanding as of Jun 30, 2026.
Financials
Maze Therapeutics reported revenue of $167.50M for fiscal 2024.
Maze Therapeutics reported a net loss of $131.12M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2024ended Dec 31, 2024 | $167.50M | — | $52.23M | 31.2% | $1.25 | $74.81M |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q1 FY2026ended Mar 31, 2026 | $20.00M | −$24.21M | −$0.45 |
| Q2 FY2025ended Jun 30, 2025 | $0.00 | −$33.68M | −$0.77 |
| Q3 FY2024ended Sep 30, 2024 | $2.50M | −$24.75M | −$10.25 |
| Q2 FY2024ended Jun 30, 2024 | $165.00M | — | — |
Company profile
- Name
- Maze Therapeutics, Inc.
- Ticker
- MAZE
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Biological Products, (No Diagnostic Substances)
- Headquarters
- 171 Oyster Point Boulevard, Suite 300, South San Francisco, CA 94080
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001842295
Recent SEC filings
- Aug 17, 2026
- Aug 11, 2026
- Aug 11, 2026
- Jun 10, 2026
- May 22, 2026
- May 12, 2026
- May 12, 2026
- Apr 22, 2026
Frequently asked questions
What is Maze Therapeutics's stock price?
Maze Therapeutics (MAZE) closed at $593.74 on Oct 9, 2026, down 0.54% from the previous close of $596.95.
What is Maze Therapeutics's market cap?
Maze Therapeutics's market cap is $32.96B, based on a share price of $593.74 and 55.5M shares outstanding as of Jun 30, 2026.
How much revenue does Maze Therapeutics make?
Maze Therapeutics reported revenue of $167.50M for fiscal 2024.
Does Maze Therapeutics pay a dividend?
Maze Therapeutics's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Maze Therapeutics, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures